Ledger.Open graph →
SEC Form D · filed December 30, 2022

Avicenna Biosciences, Inc

Offering
$6.0M
Sold
$3.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DURHAM, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Christopher Meldrum · Durham, NCExec · DirectorThomas Kaiser · Durham, NCExec · DirectorDennis Langer · Durham, NCDirectorPieter Burger · Durham, NCDirectorJohn Hamer · Durham, NCDirectorJonathan A. Bronson · Hingham, MAExec · DirectorNeil Cohen · Denver, CODirectorJoshua Gruenstein · Watertown, MADirectorAndrew Durgee · New York, NYExec · DirectorMichael A. Harstrick · Hingham, MADirectorGreg Lyons · Dallas, TXDirectorTim Woodward · San Francisco, CAExec · DirectorKenneth Hood · San Diego, CAExec · DirectorFred H. Jeffery · Safety Harbor, FLDirectorLorraine J. Hall · Matthews, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗